CSIMarket Company Name, Ticker, Customers, else..
 
Sigyn Therapeutics Inc   (RSAP)
 

Sigyn Therapeutics Inc's Suppliers Performance

RSAP's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
RSAP Costs vs Sales of Suppliers Growth

• More on RSAP Suppliers






Sigyn Therapeutics Inc's Comment on Supply Chain


The company outsources its research and product development activities, including in vitro blood plasma validation studies and animal studies, to third-party organizations with expertise in extracorporeal blood purification technologies. Pre-clinical in vitro blood plasma studies were conducted under an agreement with Innovative BioTherapies, Inc. (IBT). Animal clinical studies were performed by IBT team members through a contract with the University of Michigan, utilizing the university's animal care and surgical suite facilities. The company retains ownership of all study data collected by IBT but permits IBT to publish or present the results. The company does not plan to establish an internal research and product development facility. While suppliers such as Innovative BioTherapies, Inc. and the University of Michigan support ongoing manufacturing, disruptions or termination of vendor relationships could negatively affect the business.

Sigyn Therapeutics Inc's Comment on Supply Chain


The company outsources its research and product development activities, including in vitro blood plasma validation studies and animal studies, to third-party organizations with expertise in extracorporeal blood purification technologies. Pre-clinical in vitro blood plasma studies were conducted under an agreement with Innovative BioTherapies, Inc. (IBT). Animal clinical studies were performed by IBT team members through a contract with the University of Michigan, utilizing the university's animal care and surgical suite facilities. The company retains ownership of all study data collected by IBT but permits IBT to publish or present the results. The company does not plan to establish an internal research and product development facility. While suppliers such as Innovative BioTherapies, Inc. and the University of Michigan support ongoing manufacturing, disruptions or termination of vendor relationships could negatively affect the business.







RSAP's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Sigyn Therapeutics Inc 0.00 0.10 -3.22 14
SUBTOTAL 0.00 0.00 0.00 -


Sources: Sigyn Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Sigyn Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.